Further evidence for role of leukotrienes as mediators of decidualization in the rat.
Inhibitors of leukotrienes were utilized to investigate the role of leukotrienes (LTs) in the induction of decidualization in the rat. Alzet osmotic minipumps, filled with either FPL 55712 (FPL, a specific antagonist of peptidoleukotrienes), nordihydroguaiaretic acid (NDGA, an inhibitor of LT synthesis) or in combination with leukotriene C4 (LTC4) and/or prostaglandin E2 (PGE2), were instilled at the ovarian end of uterine horns of day 5 pseudopregnant rats. Intraluminal infusion of FPL or NDGA, for 4 days, induced a dose dependent decrease in the uterine wet weights when compared to that induced by the infusion of their corresponding vehicles (1 microliter/h). Furthermore, simultaneous infusion of LTC4 (10 ng/h) with different doses of FPL (1, 0.5, or 0.25 microgram/h) produced an increase in uterine weights as compared to that produced by FPL alone. Maximum response, however, was noted when LTC4 (10 ng/h) was infused with FPL at a rate of 0.5 microgram/h. The infusion of LTC4 (10 ng/h) or PGE2 (1 microgram/h) with NDGA, at 1 and 5 micrograms/h, could not overcome its inhibitory effect on decidualization. On the contrary, a combination of LTC4 (10 ng/h) and PGE2 (1 microgram/h) along with NDGA (5 micrograms/h) significantly increased the uterine weight to a level that was comparable to that induced by the infusion of the vehicle. To determine if the synthesis of PGs and LTs was inhibited by NDGA, one uterine horn was infused with NDGA (5 micrograms/h) and the other horn with the vehicle. The intrauterine infusion of NDGA for 24 h inhibited the release of PGE2, PGF2 alpha, LTC4 and LTB4 as compared to those released by the vehicle-infused horns. These data suggest that both PGs and LTs are required for the induction and progression of decidualization.
Tawfik
O W
OW
Department of Obstetrics and Gynecology, Ralph L. Smith Research Center, University of Kansas Medical Center, Kansas City 66103.
Dey
S K
SK
D000818:Animals; D002867:Chromones / Q000494:pharmacology; D003656:Decidua / Q000187:drug effects / Q000502:physiology*; D015237:Dinoprost; D015232:Dinoprostone; D005260:Female; D007975:Leukotriene B4 / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D009637:Masoprocol / Q000494:pharmacology; D011247:Pregnancy; D011458:Prostaglandins E / Q000378:metabolism / Q000494:pharmacology; D011460:Prostaglandins F / Q000378:metabolism; D051381:Rats; D013189:SRS-A / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*
D002867:Chromones; D011458:Prostaglandins E; D011460:Prostaglandins F; D013189:SRS-A; D007975:Leukotriene B4; D009637:Masoprocol; C006312:FPL 55712; D015237:Dinoprost; D015232:Dinoprostone